SCHEMBL7743202

SCHEMBL7743202

Fc1cc(-c2[nH]c(N3CCNCC3)nc2-c2cccc(C(F)(F)F)c2)ccn1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.60
MAPK13 O15264 2/20 0.47
MAPK9 P45984 2/20 0.47
MAPK12 P53778 2/20 0.47
MAPK11 Q15759 2/20 0.47
RAF1 P04049 1/20 0.47
ADRB1 P08588 1/20 0.46
CSNK1A1 P48729 1/20 0.44
CSNK1D P48730 1/20 0.44
RPS6KA3 P51812 1/20 0.44
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HTR1D P28221 1/20 0.44
HTR2C P28335 1/20 0.44
HTR3A P46098 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7748832 0.82 MAPK14 (0.70) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL7748833 0.82 MAPK14 (0.70) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL7750391 0.79 MAPK14 (0.54) MAPK14MAPK13MAPK9MAPK12MAPK11
Hydrochloric Acid SCHEMBL3322312 0.76 MAPT (0.57) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL3231606 0.75 MAPK14 (1.00) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL7747142 0.75 MAPK14 (0.59) MAPK14MAPK13MAPK12MAPK11
SCHEMBL4847540 0.75
SCHEMBL4842977 0.75
SCHEMBL7743195 0.74 MAPK14 (0.71) MAPK14MAPK13MAPK9MAPK12MAPK11
SCHEMBL7743194 0.74 MAPK14 (0.71) MAPK14MAPK13MAPK9MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001022965-A1 SUBSTITUTED IMIDAZOLES HAVING CYTOKINE INHIBITORY ACTIVITY MERCK & CO., INC. (US) 2001-04-05 WO disclosed
US-6083949-A FOR TREATING CANCER IN WHICH RAF KINASE IS IMPLICATED, AS WELL AS COMPOUNDS WHICH INHIBIT, SUPPRESS OR ANTAGONIZE THE PRODUCTION OR ACTIVITY OF CYTOKINES SUCH AS INTERLEUKINS AND TUMOR NECROSIS FACTOR MERCK & CO., INC. (US) 2000-07-04 US disclosed